Scott Hutton

Director at Eximis Surgical

Scott Hutton is an accomplished and strategic transformational leader with over nineteen years of experience in the medical and bio-technology industries. Scott is currently the Chief Operating Officer of Boulder, CO based Biodesix, Inc. Biodesix is a leader in developing and commercializing non-invasive, rapid turnaround, blood-based diagnostic tests for non-small cell lung cancer. Prior to joining Biodesix, Scott served as Senior Vice President and General Manager, Spectranetics Vascular Intervention, since January 2017. Prior to joining Spectranetics, Scott held several positions of increasing responsibility within various business units at Medtronic, Plc, a global healthcare products company and manufacturer of medical devices and supplies, over a period of 16 years. From April 2012 to January 2017, Mr. Hutton was Vice President and General Manager, Neurosurgery, where he oversaw the operations of the approximately $1 Billion Neurosurgery Business Unit. From 2011 to 2012, he was Vice President and Business Leader, Surgical Navigation and Intra-Operative Imaging Business. From 2008 to 2011, he was Senior Director, Global Marketing for the Medtronic Surgical Navigation and Intra-Operative Imaging Business. Prior to 2008, Scott held several positions in business development and marketing within the Spinal and Biologics business unit at Medtronic, Plc. Before joining Medtronic, Scott worked for an orthopedic medical device distributor in Southern California representing DePuy Orthopaedics (a member of the Johnson & Johnson Family of Companies) and Biomet. In July 2011, Scott received the Medtronic Wallin.


Org chart

This person is not in the org chart


Teams

This person is not in any teams